We performed NPD and ICM measurement in CF-patients and healthy controls to determine (1) the ability of these measurements to differentiate CF patients from healthy controls, and (2) the influence of smoking on CFTR function in healthy controls. This evidence concerns the gene CFTR and cystic fibrosis.